Millennium Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-468,455
| Closed | -$1.92M | – | 7861 |
|
|
2022
Q1 | $1.92M | Buy |
468,455
+362,862
| +344% | +$1.32M | ﹤0.01% | 3928 |
|
|
2021
Q4 | $377K | Sell |
105,593
-186,308
| -64% | -$652K | ﹤0.01% | 5301 |
|
|
2021
Q3 | $1.06M | Sell |
291,901
-179,353
| -38% | -$725K | ﹤0.01% | 4609 |
|
|
2021
Q2 | $2.06M | Buy |
471,254
+1,778
| +0.4% | +$7.24K | ﹤0.01% | 3925 |
|
|
2021
Q1 | $1.93M | Buy |
469,476
+407,915
| +663% | +$1.77M | ﹤0.01% | 3578 |
|
|
2020
Q4 | $246K | Buy |
61,561
+33,421
| +119% | +$108K | ﹤0.01% | 4687 |
|
|
2020
Q3 | $76 | Sell |
28,140
-463,834
| -94% | -$1.28M | ﹤0.01% | 4258 |
|
|
2020
Q2 | $1.35M | Sell |
491,974
-759,378
| -61% | -$2.12M | ﹤0.01% | 2805 |
|
|
2020
Q1 | $2.95M | Sell |
1,251,352
-460,611
| -27% | -$1.57M | 0.01% | 1743 |
|
|
2019
Q4 | $8.05M | Buy |
1,711,963
+1,697,572
| +11,796% | +$6.95M | 0.01% | 1563 |
|
|
2019
Q3 | $48K | Buy |
+14,391
| New | +$47.4K | ﹤0.01% | 4049 |
|
|
2019
Q2 | – | Sell |
-269,471
| Closed | -$816K | – | 4642 |
|
|
2019
Q1 | $816K | Sell |
269,471
-1,238,493
| -82% | -$4.01M | ﹤0.01% | 2986 |
|
|
2018
Q4 | $4.1M | Buy |
1,507,964
+816,798
| +118% | +$2.69M | 0.01% | 1719 |
|
|
2018
Q3 | $2.32M | Buy |
+691,166
| New | +$2.13M | ﹤0.01% | 2343 |
|
|
2018
Q1 | – | Sell |
-10,696
| Closed | -$21K | – | 4221 |
|
|
2017
Q4 | $21K | Sell |
10,696
-86,676
| -89% | -$189K | ﹤0.01% | 3743 |
|
|
2017
Q3 | $315K | Sell |
97,372
-296,879
| -75% | -$916K | ﹤0.01% | 3043 |
|
|
2017
Q2 | $1.27M | Sell |
394,251
-1,789,533
| -82% | -$5.07M | ﹤0.01% | 2326 |
|
|
2017
Q1 | $6.2M | Buy |
2,183,784
+1,537,528
| +238% | +$3.7M | 0.01% | 1326 |
|
|
2016
Q4 | $1.51M | Sell |
646,256
-327,186
| -34% | -$623K | ﹤0.01% | 2036 |
|
|
2016
Q3 | $1.64M | Sell |
973,442
-302,153
| -24% | -$370K | ﹤0.01% | 2037 |
|
|
2016
Q2 | $1.34M | Buy |
+1,275,595
| New | +$1.23M | ﹤0.01% | 2001 |
|
|
2016
Q1 | – | Sell |
-2,161,249
| Closed | -$2.62M | – | 3788 |
|
|
2015
Q4 | $2.62M | Buy |
2,161,249
+1,816,477
| +527% | +$2.53M | 0.01% | 1765 |
|
|
2015
Q3 | $586K | Sell |
344,772
-309,774
| -47% | -$607K | ﹤0.01% | 2576 |
|
|
2015
Q2 | $1.36M | Buy |
654,546
+249,664
| +62% | +$605K | ﹤0.01% | 2120 |
|
|
2015
Q1 | $1.1M | Sell |
404,882
-35,438
| -8% | -$89.9K | ﹤0.01% | 2266 |
|
|
2014
Q4 | $1.13M | Sell |
440,320
-3,000,655
| -87% | -$6.74M | ﹤0.01% | 2392 |
|
|
2014
Q3 | $6.3M | Sell |
3,440,975
-626,506
| -15% | -$1.37M | 0.02% | 1146 |
|
|
2014
Q2 | $10.9M | Buy |
4,067,481
+1,820,865
| +81% | +$5.48M | 0.03% | 777 |
|
|
2014
Q1 | $7.86M | Buy |
2,246,616
+103,217
| +5% | +$458K | 0.02% | 944 |
|
|
2013
Q4 | $9.58M | Buy |
2,143,399
+2,109,567
| +6,235% | +$8.6M | 0.03% | 744 |
|
|
2013
Q3 | $137K | Buy |
+33,832
| New | +$148K | ﹤0.01% | 3164 |
|
Other funds holding ATRS
Millennium Management's ATRS Position: Q2 2022 in Review
Millennium Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 468,455 shares — an estimated $1.92M sold.
Millennium Management first reported a position in ATRS in Q3 2013 and held it in 31 quarters. The position peaked at $10.9M in Q2 2014. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Millennium Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Millennium Management sold 468,455 Antares Pharma, Inc. shares in Q2 2022, an estimated $1.92M.
- Millennium Management first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 31 quarters.
- Millennium Management's Antares Pharma, Inc. position peaked at $10.9M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.